Ruxolitinib Versus Best Available Therapy for Polycythemia Vera Intolerant or Resistant to Hydroxycarbamide in a Randomized Trial

Claire N. Harrison; Jyoti Nangalia; Rebecca Boucher; Aimee Jackson; Christina Yap; Jennifer O'Sullivan; Sonia Fox; Isaak Ailts; Amylou C. Dueck; Holly L. Geyer; Ruben A. Mesa; William G. Dunn; Eugene Nadezhdin; Natalia Curto-Garcia; Anna Green; Bridget Wilkins; Jason Coppell; John Laurie; Mamta Garg; Joanne Ewing; Steven Knapper; Josephine Crowe; Frederick Chen; Ioannis Koutsavlis; Anna Godfrey; Siamak Arami; Mark Drummond; Jennifer Byrne; Fiona Clark; Carolyn Mead-Harvey; Elizabeth Joanna Baxter; Mary Frances McMullin; Adam J. Mead

doi:10.1200/JCO.22.01935

Ruxolitinib Versus Best Available Therapy for Polycythemia Vera Intolerant or Resistant to Hydroxycarbamide in a Randomized Trial

Claire N. Harrison, Jyoti Nangalia, Rebecca Boucher, Aimee Jackson, Christina Yap, Jennifer O'Sullivan, Sonia Fox, Isaak Ailts, Amylou C. Dueck, Holly L. Geyer, Ruben A. Mesa, William G. Dunn, Eugene Nadezhdin, Natalia Curto-Garcia, Anna Green, Bridget Wilkins, Jason Coppell, John Laurie, Mamta Garg, Joanne EwingSteven Knapper, Josephine Crowe, Frederick Chen, Ioannis Koutsavlis, Anna Godfrey, Siamak Arami, Mark Drummond, Jennifer Byrne, Fiona Clark, Carolyn Mead-Harvey, Elizabeth Joanna Baxter, Mary Frances McMullin, Adam J. Mead

科研成果: 期刊稿件 › 文章 › 同行评审

62 引用（Scopus）

源语言	英语
页（从-至）	3534-3544
页数	11
期刊	Journal of Clinical Oncology
卷	41
期	19
DOI	https://doi.org/10.1200/JCO.22.01935
出版状态	已出版 - 7月 1 2023
已对外发布	是

!!!ASJC Scopus Subject Areas

肿瘤学
癌症研究

联合国可持续发展目标

此成果有助于实现下列可持续发展目标：

访问文件

10.1200/JCO.22.01935

其它文件与链接

引用此

Harrison, C. N., Nangalia, J., Boucher, R., Jackson, A., Yap, C., O'Sullivan, J., Fox, S., Ailts, I., Dueck, A. C., Geyer, H. L., Mesa, R. A., Dunn, W. G., Nadezhdin, E., Curto-Garcia, N., Green, A., Wilkins, B., Coppell, J., Laurie, J., Garg, M., ... Mead, A. J. (2023). Ruxolitinib Versus Best Available Therapy for Polycythemia Vera Intolerant or Resistant to Hydroxycarbamide in a Randomized Trial. Journal of Clinical Oncology, 41(19), 3534-3544. https://doi.org/10.1200/JCO.22.01935

Harrison, CN, Nangalia, J, Boucher, R, Jackson, A, Yap, C, O'Sullivan, J, Fox, S, Ailts, I, Dueck, AC, Geyer, HL, Mesa, RA, Dunn, WG, Nadezhdin, E, Curto-Garcia, N, Green, A, Wilkins, B, Coppell, J, Laurie, J, Garg, M, Ewing, J, Knapper, S, Crowe, J, Chen, F, Koutsavlis, I, Godfrey, A, Arami, S, Drummond, M, Byrne, J, Clark, F, Mead-Harvey, C, Baxter, EJ, McMullin, MF & Mead, AJ 2023, 'Ruxolitinib Versus Best Available Therapy for Polycythemia Vera Intolerant or Resistant to Hydroxycarbamide in a Randomized Trial', Journal of Clinical Oncology, 卷 41, 号码 19, 页码 3534-3544. https://doi.org/10.1200/JCO.22.01935

@article{663b9f4b410241dcb861f4003bbd1ee5,

title = "Ruxolitinib Versus Best Available Therapy for Polycythemia Vera Intolerant or Resistant to Hydroxycarbamide in a Randomized Trial",

author = "Harrison, {Claire N.} and Jyoti Nangalia and Rebecca Boucher and Aimee Jackson and Christina Yap and Jennifer O'Sullivan and Sonia Fox and Isaak Ailts and Dueck, {Amylou C.} and Geyer, {Holly L.} and Mesa, {Ruben A.} and Dunn, {William G.} and Eugene Nadezhdin and Natalia Curto-Garcia and Anna Green and Bridget Wilkins and Jason Coppell and John Laurie and Mamta Garg and Joanne Ewing and Steven Knapper and Josephine Crowe and Frederick Chen and Ioannis Koutsavlis and Anna Godfrey and Siamak Arami and Mark Drummond and Jennifer Byrne and Fiona Clark and Carolyn Mead-Harvey and Baxter, {Elizabeth Joanna} and McMullin, {Mary Frances} and Mead, {Adam J.}",

note = "Publisher Copyright: {\textcopyright} American Society of Clinical Oncology.",

year = "2023",

month = jul,

day = "1",

doi = "10.1200/JCO.22.01935",

language = "English",

volume = "41",

pages = "3534--3544",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "American Society of Clinical Oncology",

number = "19",

}

TY - JOUR

T1 - Ruxolitinib Versus Best Available Therapy for Polycythemia Vera Intolerant or Resistant to Hydroxycarbamide in a Randomized Trial

AU - Harrison, Claire N.

AU - Nangalia, Jyoti

AU - Boucher, Rebecca

AU - Jackson, Aimee

AU - Yap, Christina

AU - O'Sullivan, Jennifer

AU - Fox, Sonia

AU - Ailts, Isaak

AU - Dueck, Amylou C.

AU - Geyer, Holly L.

AU - Mesa, Ruben A.

AU - Dunn, William G.

AU - Nadezhdin, Eugene

AU - Curto-Garcia, Natalia

AU - Green, Anna

AU - Wilkins, Bridget

AU - Coppell, Jason

AU - Laurie, John

AU - Garg, Mamta

AU - Ewing, Joanne

AU - Knapper, Steven

AU - Crowe, Josephine

AU - Chen, Frederick

AU - Koutsavlis, Ioannis

AU - Godfrey, Anna

AU - Arami, Siamak

AU - Drummond, Mark

AU - Byrne, Jennifer

AU - Clark, Fiona

AU - Mead-Harvey, Carolyn

AU - Baxter, Elizabeth Joanna

AU - McMullin, Mary Frances

AU - Mead, Adam J.

PY - 2023/7/1

Y1 - 2023/7/1

UR - http://www.scopus.com/inward/record.url?scp=85162987090&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85162987090&partnerID=8YFLogxK

U2 - 10.1200/JCO.22.01935

DO - 10.1200/JCO.22.01935

M3 - Article

C2 - 37126762

AN - SCOPUS:85162987090

SN - 0732-183X

VL - 41

SP - 3534

EP - 3544

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 19

ER -

Ruxolitinib Versus Best Available Therapy for Polycythemia Vera Intolerant or Resistant to Hydroxycarbamide in a Randomized Trial

!!!ASJC Scopus Subject Areas

联合国可持续发展目标

访问文件

其它文件与链接

指纹

引用此